Abstract

Boceprevir dosing for late responders and null responders: The role of bridging data between treatment-naïve and -experienced subjects

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call